Evaluation and comparison of luteal phase support with vaginal and oral progesterone in IUI in Kernan in 2022

Phase 3

Recruiting

• Conditions: Infertility.; Complication associated with artificial fertilization, unspecified; N98.9

• Registration Number: IRCT20151004024335N5
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 288

Inclusion Criteria

Infertile women with unexplained infertility
Infertility with a mild male factor
Infertility due to polycystic ovary syndrome who have not responded to drug treatment alone
Age 18 to 40 years

Exclusion Criteria

Three times more history of unsuccessful intra uterine sperm insemination treatment
azoospermia or Severe spermogram disorder
Presence of endocrine diseases such as diabetes and severe thyroid disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: Measurement of serum beta-HCG.

Secondary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: Five weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Miscarriage rate. Timepoint: miscarriages before 20 weeks gestation. Method of measurement: Contact patients at the 20th week of pregnancy.